Search research articles
Contact Us
Filters
Showing results (21-30 of 167) with videos related to
Page
of 17
Sort By:
The New England Journal of Medicine
|
November 12, 2013
Health disparities in kidney disease--emerging data from the human genome
Winfred W Williams, Martin R Pollak
Nature Medicine
|
August 6, 2011
A suPAR circulating factor causes kidney disease
Stuart J Shankland, Martin R Pollak
Circulation
|
October 22, 2015
Effect Size Does Matter: The Long Road to Mechanistic Insight From Genome-Wide Association
Calum A MacRae, Martin R Pollak
Trends in Endocrinology and Metabolism: TEM
|
March 8, 2016
Apolipoprotein L1 and Kidney Disease in African Americans
David J Friedman, Martin R Pollak
Current Opinion in Nephrology and Hypertension
|
July 4, 2014
The role of the calcium-sensing receptor in disorders of abnormal calcium handling and cardiovascular disease
Hakan R Toka, Martin R Pollak
Journal of the American Society of Nephrology : JASN
|
September 18, 2010
VEGF receptors and glomerular function
Samir M Parikh, Martin R Pollak
Current Opinion in Nephrology and Hypertension
|
March 6, 2025
APOL1-associated kidney disease: modulators of the genotype-phenotype relationship
Martin R Pollak, David J Friedman
American Journal of Physiology. Renal Physiology
|
January 25, 2018
Mechanical challenges and cytoskeletal impairments in focal segmental glomerulosclerosis
Di Feng, Clark DuMontier, Martin R Pollak
Micromachines
|
September 23, 2022
Disease Modeling with Kidney Organoids
Sophie Karp, Martin R Pollak, Balajikarthick Subramanian
Cell & Bioscience
|
August 25, 2015
The role of alpha-actinin-4 in human kidney disease
Di Feng, Clark DuMontier, Martin R Pollak
Page
of 17
Search research articles
Search
Showing results (21-30 of 167) with videos related to
Sort By:
Page
of 17
The New England Journal of Medicine
|
November 12, 2013
Health disparities in kidney disease--emerging data from the human genome
Winfred W Williams, Martin R Pollak
Nature Medicine
|
August 6, 2011
A suPAR circulating factor causes kidney disease
Stuart J Shankland, Martin R Pollak
Circulation
|
October 22, 2015
Effect Size Does Matter: The Long Road to Mechanistic Insight From Genome-Wide Association
Calum A MacRae, Martin R Pollak
Trends in Endocrinology and Metabolism: TEM
|
March 8, 2016
Apolipoprotein L1 and Kidney Disease in African Americans
David J Friedman, Martin R Pollak
Current Opinion in Nephrology and Hypertension
|
July 4, 2014
The role of the calcium-sensing receptor in disorders of abnormal calcium handling and cardiovascular disease
Hakan R Toka, Martin R Pollak
Journal of the American Society of Nephrology : JASN
|
September 18, 2010
VEGF receptors and glomerular function
Samir M Parikh, Martin R Pollak
Current Opinion in Nephrology and Hypertension
|
March 6, 2025
APOL1-associated kidney disease: modulators of the genotype-phenotype relationship
Martin R Pollak, David J Friedman
American Journal of Physiology. Renal Physiology
|
January 25, 2018
Mechanical challenges and cytoskeletal impairments in focal segmental glomerulosclerosis
Di Feng, Clark DuMontier, Martin R Pollak
Micromachines
|
September 23, 2022
Disease Modeling with Kidney Organoids
Sophie Karp, Martin R Pollak, Balajikarthick Subramanian
Cell & Bioscience
|
August 25, 2015
The role of alpha-actinin-4 in human kidney disease
Di Feng, Clark DuMontier, Martin R Pollak
Page
of 17